Patient Services Research. Project 3: Parent Focused Intervention to Improve Academic Success in Children with SCD Children with sickle cell disease (SCD) are at risk for a variety of central nervous system (CMS) complications, including overt clinical stroke, silent infarction, increased cerebral blood flow rates, and possibly microvascular infarction not grossly detected by neuroimaging. These CNS events affect neuropsychological performance and academic achievement (Schatz &Puffer, 2006). Children who experience CNS injury because of SCD are also at higher risk for behavior and adjustment challenges (Trzepacz, et al., 2004), although behavior problems are also associated with higher family conflict (Thompson et al., 1999). Family conflict has been identified as a significant stressor, and associated with more difficulty dealing with sickle cell disease symptoms, particularly pain (Gil et al., 2003). A biopsychosocial model of SCD (Armstrong, 2006) suggests that these factors may be interrelated, and implementing positive change in one area will benefit the other areas of function.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HL090569-03
Application #
8261341
Study Section
Special Emphasis Panel (ZHL1)
Project Start
Project End
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
3
Fiscal Year
2011
Total Cost
$71,636
Indirect Cost
Name
University of Miami School of Medicine
Department
Type
DUNS #
052780918
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Armstrong, F Daniel; Elkin, T David; Brown, R Clark et al. (2013) Developmental function in toddlers with sickle cell anemia. Pediatrics 131:e406-14
Lo, Joan C; Sinaiko, Alan; Chandra, Malini et al. (2013) Prehypertension and hypertension in community-based pediatric practice. Pediatrics 131:e415-24
Armstrong, F Daniel (2010) Neurocognitive function in sickle cell disease: have we been missing something? Expert Rev Hematol 3:519-21